GNG5 and central nervous system cancer: Glioma patients with high GNG5 expression had shorter overall survival (OS; P < .0001; Figure 2R) and disease‐free survival (DFS; P < .0001; Figure 2S) compared with the low GNG5 group using the GEPIA2.